1Furlanetto RW. Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Hormone Re search 1990;33(Suppl 4):25-30.
2Berelowitz M, Szabo M, Frohman LA, et al.Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and pituitary. Science 1981 ;212:1279- 1281.
3MacGillivray M.H. Disorders of growth and development. In: Felig P. BaxterJ.D. Broadus A.E. Frohman L.A., editors. En docrinology and metabolism. New York: McGraw-Hill, 1981 p.1581-1628.
4Clemmons DR, Van Wyk JJ. Factors controlling blood con centration ofsomatomedin C. Clinics in Endocrinology and Metabolism.1984; 13:113-143.
5Rupprecht R, Rupprecht C, Rupprecht M, et al. Effect ofglu cocorticoids on the regulation of the hypothalamic-pituitary- somatotropic system in depression. Journal ofAffective Disor ders. 1989;17:9-16.
6Deuschle M, Blum WF, Strasburger C J, et al. Insulin-like growth factor I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology. 1997;22: 493-503.
7Franz B, Buysse D J, Cherry CR, et al. Insulin-like growth fac tor 1 and growth hormone binding protein in depression:a pre liminarycommunication3ofPsyc hiatrRes1999,33(2):121-127.
